Lung cancer (also called “bronchogenic carcinoma”) is an uncontrollable growth of abnormal cells in pulmonary tissue. Lung carcinomas are responsible for approximately 1.3 million deaths per year worldwide.

Traditional Treatments

The possible traditional treatments are surgery, chemotherapy and interventional therapy.

Cutting-edge therapies available in China Cancer Centers (CCC) for lung cancer may consist of:
For early stage non-small cell lung cancer
   Surgery
   CIK-DC immunotherapy

Features
1. Efficient prevention of recurrence and metastasis. CIK-DC cell immunotherapy eliminates cancerous cells which may have spread before the surgery and restore human’s immune system against cancer.
2. No toxin or side effects
3. Good quality of life
4. Improve the rate of cancer cures

For advanced stage non-small cell lung cancer
    Cryoablation
    Gene therapy
    Antiangionesis therapy
    Chemotherapy
    CIK-DC immunotherapy

Features:
1. Cryoablation is minimally invasive surgery, with little harm to normal function and little pains to patients, small incisions and quick recovery.
2. CIK biotherapy, enhances the efficacy of cryoablation and mild chemotherapy, as well as improves the immune function against tumors.
3. Low toxicity or side effects to human body.
4. Significantly extends survival time with a good quality of life.

Read more about our cases:

Lung Cancer - Ms. D - 55 yrs - Netherland - June 2007

Lung Cancer-N/A-55 yrs-Netherlands-June 2007

Small Cell Lung Carcinoma-Mr. Wang-56 yrs-China-Aug. 2006 

Bronchogenic carcinoma - Mr. Wang - 42 yrs. - China - Feb. 2006 

Lung Adenocarcinoma -Mr. Duan-62 yrs-China-Feb. 2005

Central bronchogenic lung carcinoma-Ms. Hao-47 yrs-China-April 2004